Artificial intelligence can elevate pharma manufacturing

Any unnecessary downtime can be expensive for pharmaceutical manufacturing operations. What's more, unplanned stoppages can delay the delivery of much-needed product, potentially causing damage to a company's reputation. David Leitham, senior vice president and general manager at industrial artificial intelligence (AI) technology firm AspenTech, recently spoke with Outsourcing-Pharma (OSP) about how AI can be put to use to help predict when maintenance is needed, and avoid unplanned or over-maintenance. OSP: Could you please share an'elevator presentation' description of AspenTech? DL: AspenTech develops software to help customers in capital-intensive industries (such as energy, chemicals, and pharmaceuticals), address their biggest challenges: delivering increased value to stakeholders, responding to an evolving global population, and reducing environmental impact and waste.